BEESIX® TABLETS
Country: South Africa
Language: English
Source: South African Health Products Regulatory Authority (SAHPRA)
Patient Information leaflet
(PIL)
19-04-2024
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
Sad-otc
Patient Information leaflet
BEESIX® TABLETS
SCHEDULING STATUS:
Not Scheduled.
PROPRIETARY NAME
(and dosage form):
BEESIX
®
TABLETS
COMPOSITION:
Each tablet contains:
Pyridoxine
Hydrochloride 25,00 mg
PHARMACOLOGICAL CLASSIFICATION:
A 22.1.4 Vitamins - Other.
PHARMACOLOGICAL ACTION:
Pyridoxine Hydrochloride (vitamin B6) is converted in the body to pyridoxal phosphate which serves a vital role in
metabolism as a co-enzyme for a wide variety of metabolic transformations of amino acids.
INDICATIONS:
Treatment and prevention of vitamin B6 deficiency.
CONTRA-INDICATIONS:
Pyridoxine administration should be avoided in patients receiving levodopa therapy.
DOSAGE AND DIRECTIONS FOR USE:
One to six tablets daily in divided doses.
PRESENTATION:
25 and 100 tablets.
STORAGE INSTRUCTIONS:
Store below 25 °C.
Protect from light, heat and moisture.
KEEP OUT OF REACH OF CHILDREN.
APPLICATION NUMBER:
H.2026 [Act 101/1965]
NAME AND BUSINESS ADDRESS OF APPLICANT:
S.A.D. SELF MEDICATION [PTY] LIMITED
Co. Reg. No. 92/04769/07
Robbie de Lange Road, Wilsonia, EAST LONDON, 5201
P O Box 422, EAST LONDON, 5200
DATE OF PUBLICATION OF THIS PACKAGE INSERT:
25 November 1974
Read the complete document
